Covered recipient · General Payments record
STACEY J BURNS
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$2,601.65
- Reported across 181 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $297.86 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $87.07 | 4 |
| Novo Nordisk AS | $62.97 | 4 |
| iRhythm Technologies, Inc. | $50.54 | 1 |
| Amgen Inc. | $31.47 | 2 |
| PFIZER INC. | $28.07 | 2 |
| Antares Pharma, Inc. | $15.83 | 1 |
| Astellas Pharma US Inc | $13.26 | 1 |
| CeQur Corporation | $8.65 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.27 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103394823 | CMS |
| ABBVIE INC. | $28.96 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103394825 | CMS |
| ABBVIE INC. | $17.01 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103394827 | CMS |
| ABBVIE INC. | $14.83 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103394829 | CMS |
| Amgen Inc. | $14.26 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115471237 | CMS |
| Amgen Inc. | $17.21 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115471243 | CMS |
| Antares Pharma, Inc. | $15.83 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146451359 | CMS |
| Astellas Pharma US Inc | $13.26 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139441450 | CMS |
| CeQur Corporation | $8.65 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126845434 | CMS |
| iRhythm Technologies, Inc. | $50.54 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154055246 | CMS |
| Novo Nordisk Inc | $15.06 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097298575 | CMS |
| Novo Nordisk Inc | $18.75 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096610646 | CMS |
| Novo Nordisk Inc | $14.73 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097045391 | CMS |
| Novo Nordisk Inc | $14.43 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097461431 | CMS |
| PFIZER INC. | $14.52 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131672000 | CMS |
| PFIZER INC. | $13.55 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131115443 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.